194 related articles for article (PubMed ID: 28151756)
1. Recent developments in the management of germ cell tumors.
Msaouel P; Bilen MA; Zhang M; Campbell M; Wang J; Tu SM
Curr Opin Oncol; 2017 May; 29(3):172-178. PubMed ID: 28151756
[TBL] [Abstract][Full Text] [Related]
2. Managing seminomatous and nonseminomatous germ cell tumors.
Chahoud J; Zhang M; Shah A; Lin SH; Pisters LL; Tu SM
Curr Opin Oncol; 2018 May; 30(3):181-188. PubMed ID: 29538040
[TBL] [Abstract][Full Text] [Related]
3. Contemporary management of postchemotherapy testis cancer.
Daneshmand S; Albers P; Fosså SD; Heidenreich A; Kollmannsberger C; Krege S; Nichols C; Oldenburg J; Wood L
Eur Urol; 2012 Nov; 62(5):867-76. PubMed ID: 22938868
[TBL] [Abstract][Full Text] [Related]
4. Conventional-Dose versus High-Dose Chemotherapy for Relapsed Germ Cell Tumors.
McHugh DJ; Feldman DR
Adv Urol; 2018; 2018():7272541. PubMed ID: 29736168
[TBL] [Abstract][Full Text] [Related]
5. Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database.
Lorch A; Bascoul-Mollevi C; Kramar A; Einhorn L; Necchi A; Massard C; De Giorgi U; Fléchon A; Margolin K; Lotz JP; Germà-Lluch JR; Powles T; Kollmannsberger C; Beyer J
J Clin Oncol; 2011 Jun; 29(16):2178-84. PubMed ID: 21444870
[TBL] [Abstract][Full Text] [Related]
6. Risk-Stratified Initial Salvage Therapy for Relapsed or Refractory Metastatic Germ Cell Tumors.
Narayan V; Gunnarsson O; Hwang WT; Squillante CM; Nathanson KL; Stadtmauer EA; Vaughn DJ
Clin Genitourin Cancer; 2016 Dec; 14(6):524-529. PubMed ID: 27083130
[TBL] [Abstract][Full Text] [Related]
7. The role of high-dose chemotherapy in the management of germ cell tumors.
Bastos DA; Feldman DR
Curr Opin Oncol; 2014 May; 26(3):284-93. PubMed ID: 24670607
[TBL] [Abstract][Full Text] [Related]
8. Intensified chemotherapy with stem-cell rescue in germ-cell tumors.
Simonelli M; Rosti G; Banna GL; Pedrazzoli P; ;
Ann Oncol; 2012 Apr; 23(4):815-22. PubMed ID: 21948814
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes and histological findings of patients with advanced metastatic germ cell tumors undergoing post-chemotherapy resection of retroperitoneal lymph nodes and residual extraretroperitoneal masses.
Nakamura T; Oishi M; Ueda T; Fujihara A; Nakanishi H; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
Int J Urol; 2015 Jul; 22(7):663-8. PubMed ID: 25847721
[TBL] [Abstract][Full Text] [Related]
10. Salvage high-dose chemotherapy for germ cell tumors.
Feldman DR; Powles T
Urol Oncol; 2015 Aug; 33(8):355-62. PubMed ID: 25837842
[TBL] [Abstract][Full Text] [Related]
11. Clinical stage I nonseminomatous testicular germ-cell tumors: surgery or watchful waiting, still an issue?
Heidenreich A
Curr Opin Urol; 2002 Sep; 12(5):427-30. PubMed ID: 12172431
[TBL] [Abstract][Full Text] [Related]
12. Genetic analysis of mediastinal nonseminomatous germ cell tumors in children and adolescents.
Schneider DT; Schuster AE; Fritsch MK; Calaminus G; Göbel U; Harms D; Lauer S; Olson T; Perlman EJ
Genes Chromosomes Cancer; 2002 May; 34(1):115-25. PubMed ID: 11921289
[TBL] [Abstract][Full Text] [Related]
13. Large retroperitoneal lymphadenopathy as a predictor of venous thromboembolism in patients with disseminated germ cell tumors treated with chemotherapy.
Srikanthan A; Tran B; Beausoleil M; Jewett MA; Hamilton RJ; Sturgeon JF; O'Malley M; Anson-Cartwright L; Chung PW; Warde PR; Winquist E; Moore MJ; Amir E; Bedard PL
J Clin Oncol; 2015 Feb; 33(6):582-7. PubMed ID: 25605848
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of salvage high-dose chemotherapy in patients with germ cell tumor with poor prognostic features.
De Giorgi U; Rosti G; Salvioni R; Papiani G; Ballardini M; Pizzocaro G; Marangolo M
Urol Oncol; 2011; 29(3):284-90. PubMed ID: 19556152
[TBL] [Abstract][Full Text] [Related]
15. High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors.
Lorch A; Neubauer A; Hackenthal M; Dieing A; Hartmann JT; Rick O; Bokemeyer C; Beyer J
Ann Oncol; 2010 Apr; 21(4):820-825. PubMed ID: 19822531
[TBL] [Abstract][Full Text] [Related]
16. High-dose chemotherapy with hematopoietic stem-cell support in germ-cell tumor patient treatment: the French experience.
Fléchon A; Biron P; Droz JP
Int J Cancer; 1999 Dec; 83(6):844-7. PubMed ID: 10597208
[TBL] [Abstract][Full Text] [Related]
17. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
[No Abstract] [Full Text] [Related]
18. Current chemotherapeutic approaches for recurrent or refractory germ cell tumors.
O'Carrigan B; Grimison P
Urol Oncol; 2015 Aug; 33(8):343-54. PubMed ID: 25308563
[TBL] [Abstract][Full Text] [Related]
19. [High dose chemotherapy with autologous stem-cell support in germ cell tumors: The Instituto Português de Oncologia de Lisboa Francisco Gentil Series].
Brito M; Sanchez P; Velho S; Miranda N; Leal da Costa F; Ferreira I; Teixeira G; Guimarães A; Abecasis M; Passos Coelho JL
Acta Med Port; 2011; 24(4):533-44. PubMed ID: 22521011
[TBL] [Abstract][Full Text] [Related]
20. Surgical Management of Patients with Advanced Germ Cell Tumors Following Salvage Chemotherapy: Memorial Sloan Kettering Cancer Center (MSKCC) Experience.
Miller MI; Feifer A; Feldman DR; Carver BS; Bosl GJ; Motzer RJ; Bajorin DF; Sheinfeld J
Urology; 2019 Feb; 124():174-178. PubMed ID: 30296502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
